Literature DB >> 33857736

Ximaoglaucumins A - F, new cembranoids with anti-inflammatory activities from the South China Sea soft coral Sarcophyton glaucum.

Shou-Mao Shen1, Wang-Sheng Li2, Xun Ding3, Hui Luo4, Hai-Yan Zhang5, Yue-Wei Guo6.   

Abstract

Six new cembrane-type diterpenoids, namely ximaoglaucumins A-F (1-6), along with fifteen known related ones (7-10 and 14-24), have been isolated from the soft coral Sarcophyton glaucum collected off the Ximao Island in the South China Sea. Their structures, including absolute stereochemistry, were elucidated by extensive spectroscopic analysis, quantum mechanical nuclear magnetic resonance (QM-NMR) methods, X-ray diffraction analysis, chemical methods, as well as comparison with the reported data in the literature. Further, detailed analysis of spectroscopic data of 7 not only clarified the confusions regarding 7, 11 (sarcophytolol) and 12/13 (sarcotrocheliol) in the literature, but also led to revise the structure of 11, which was mis-assigned due to careless/erroneous interpretation of the 2D NMR spectra, and to correct the structures of 12/13, which were both wrongly depicted. In in vitro bioassay, compounds 8 and 20 exhibited potent inhibitory effects on lipopolysaccharide (LPS)-induced inflammatory responses in BV-2 microglial cells.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anti-inflammation; Cembranoids; Sarcophyton glaucum; Soft coral

Year:  2021        PMID: 33857736     DOI: 10.1016/j.bmc.2021.116139

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

Review 1.  Chemistry and bioactivity of secondary metabolites from South China Sea marine fauna and flora: recent research advances and perspective.

Authors:  Jiao Liu; Yu-Cheng Gu; Ming-Zhi Su; Yue-Wei Guo
Journal:  Acta Pharmacol Sin       Date:  2022-09-14       Impact factor: 7.169

2.  Sarcoeleganolides C-G, Five New Cembranes from the South China Sea Soft Coral Sarcophyton elegans.

Authors:  Cili Wang; Jiarui Zhang; Xing Shi; Kai Li; Fengling Li; Xuli Tang; Guoqiang Li; Pinglin Li
Journal:  Mar Drugs       Date:  2022-09-10       Impact factor: 6.085

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.